Cancer Biomarkers: Understanding EGFR and ALK Testing
Did you know that 10 to 15% of lung cancers in the United States have EGFR mutations? These mutations are […]
Precision Medicine
Types of Biomarkers for Lung Cancer: A Complete Guide
Lung cancer leads to about one-third of all cancer deaths worldwide. This fact shows the urgent need for better ways
Tailoring treatments based on genetic markers and mutations
Did you know treatments customized to genetic resistance can succeed 84% of the time? This amazing fact shows how precision
Biomarker Testing: Key to Lung Cancer Detection
Did you know? Over half of people with advanced lung cancer have a specific biomarker. These biomarkers are essential in
What is Biomarker Testing? – A Medical Guide
Did you know that nearly 70% of cancer patients may see benefits from biomarker testing? This type of testing can
DXD: A New Hope for Dato-DXD Lung Cancer Treatment
Approximately 2.5 million cases of lung cancer were discovered worldwide in 2022. Most of these, about 80%, were diagnosed as
Discover the Newest Treatment for Lung Cancer Today
Lung cancer is the deadliest cancer in the United States, with about 130,000 deaths in 2023. But there’s hope. New
Challenges and Future of Biomarker-Based Risk Prediction
Did you know that techniques like Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) are FDA-approved? They are used in
Biomarker Testing in Lung Cancer: What to Know
Did you know over 70% of lung cancer patients see benefits from biomarker testing? It identifies specific genetic mutations. These
Biomarker Panels in Early Detection: Future of Screening
In 2020, cancer was behind nearly 10 million deaths worldwide. It ranks as the second leading cause of death globally.